Difference between revisions of "Aldesleukin (Proleukin)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>")
(updated content)
Line 1: Line 1:
 +
Also known as interleukin-2, IL-2.
 +
 
==General information==
 
==General information==
Class/mechanism: Recombinant IL-2, immune system activation.<ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/proleukin.pdf Aldesleukin package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/aldesleukin.pdf Aldesleukin package insert (locally hosted backup)]</ref>
+
Class/mechanism: Recombinant interleukin-2 which activates the immune system.  Aldesleukin encourages growth of IL-2 dependent cells, triggers natural killer (NK) and lymphokine-activated killer (LAK) cell activity, induces production of interferon gamma, and increases lymphocyte cytotoxicity.<ref name="insert">[http://www.proleukin.com/assets/proleukin.pdf Aldesleukin (Proleukin) package insert]</ref><ref>[[Media:Aldesleukin.pdf | Aldesleukin (Proleukin) package insert (locally hosted backup)]]</ref><ref>[http://www.proleukin.com/ Proleukin manufacturer's website]</ref>
 
<br>Route: IV
 
<br>Route: IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 +
 +
==Diseases for which it is used==
 +
*[[Bone cancer]]
 +
*[[Melanoma]]
 +
*[[Renal cancer]]
  
 
==Patient drug information==
 
==Patient drug information==
*[http://chemocare.com/bio/aldesleukin.asp Aldesleukin (Proleukin) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/aldesleukin.asp Aldesleukin (Proleukin) patient drug information (Chemocare)]</ref>
+
*[http://chemocare.com/chemotherapy/drug-info/aldesleukin.aspx Aldesleukin (Proleukin) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/aldesleukin.aspx Aldesleukin (Proleukin) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]</ref>
  
 
==References==
 
==References==
 
<references/>
 
<references/>

Revision as of 03:37, 5 October 2012

Also known as interleukin-2, IL-2.

General information

Class/mechanism: Recombinant interleukin-2 which activates the immune system. Aldesleukin encourages growth of IL-2 dependent cells, triggers natural killer (NK) and lymphokine-activated killer (LAK) cell activity, induces production of interferon gamma, and increases lymphocyte cytotoxicity.[1][2][3]
Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

References